43.46
0.70%
0.30
Dopo l'orario di chiusura:
43.46
Precedente Chiudi:
$43.16
Aprire:
$43.09
Volume 24 ore:
538.23K
Relative Volume:
0.59
Capitalizzazione di mercato:
$2.92B
Reddito:
$2.82B
Utile/perdita netta:
$-1.87B
Rapporto P/E:
-1.5577
EPS:
-27.9
Flusso di cassa netto:
$-96.80M
1 W Prestazione:
-1.76%
1M Prestazione:
-2.45%
6M Prestazione:
+10.61%
1 anno Prestazione:
-36.56%
Quidelortho Corporation Stock (QDEL) Company Profile
Nome
Quidelortho Corporation
Settore
Industria
Telefono
(858) 552-1100
Indirizzo
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Confronta QDEL con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
QDEL
Quidelortho Corporation
|
43.46 | 2.92B | 2.82B | -1.87B | -96.80M | -27.90 |
ABT
Abbott Laboratories
|
127.93 | 221.89B | 41.95B | 13.40B | 6.49B | 7.65 |
BSX
Boston Scientific Corp
|
102.36 | 150.86B | 15.91B | 1.79B | 1.89B | 1.21 |
SYK
Stryker Corp
|
391.29 | 149.17B | 22.60B | 2.99B | 3.49B | 7.76 |
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
72.45 | 42.73B | 6.60B | 4.16B | 490.10M | 6.93 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
2024-12-10 | Iniziato | Jefferies | Hold |
2024-09-19 | Ripresa | UBS | Neutral |
2024-09-05 | Aggiornamento | Craig Hallum | Hold → Buy |
2024-03-04 | Downgrade | UBS | Neutral → Sell |
2024-02-14 | Downgrade | JP Morgan | Neutral → Underweight |
2023-12-11 | Downgrade | Citigroup | Buy → Neutral |
2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
2022-10-14 | Aggiornamento | UBS | Sell → Neutral |
2022-09-19 | Iniziato | Citigroup | Neutral |
2022-07-20 | Iniziato | UBS | Sell |
2022-06-17 | Ripresa | JP Morgan | Neutral |
2022-02-22 | Aggiornamento | Raymond James | Outperform → Strong Buy |
2021-01-22 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2020-05-12 | Downgrade | JP Morgan | Neutral → Underweight |
2020-03-26 | Downgrade | Barclays | Overweight → Equal Weight |
2018-10-23 | Ripresa | Raymond James | Strong Buy |
2018-03-08 | Aggiornamento | Raymond James | Outperform → Strong Buy |
2018-01-22 | Reiterato | Barclays | Overweight |
2018-01-04 | Aggiornamento | CL King | Neutral → Buy |
2017-09-19 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
2017-07-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
2017-07-18 | Aggiornamento | William Blair | Mkt Perform → Outperform |
2017-04-25 | Reiterato | Canaccord Genuity | Hold |
2017-02-17 | Iniziato | CL King | Neutral |
2016-12-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
2016-06-13 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2016-02-18 | Reiterato | Barclays | Overweight |
2016-02-09 | Downgrade | Canaccord Genuity | Buy → Hold |
2016-01-08 | Reiterato | Canaccord Genuity | Buy |
2015-12-14 | Downgrade | Raymond James | Outperform → Mkt Perform |
2015-09-02 | Iniziato | Barclays | Overweight |
2013-07-31 | Reiterato | Canaccord Genuity | Buy |
2011-03-03 | Downgrade | Wedbush | Outperform → Neutral |
Mostra tutto
Quidelortho Corporation Borsa (QDEL) Ultime notizie
QuidelOrtho Co. (NASDAQ:QDEL) Shares Sold by EMC Capital Management - MarketBeat
Why QuidelOrtho Stock Blasted 10% Higher Today - MSN
QuidelOrtho Corporation – Consensus ‘none’ rating and 17.5% Upside Potential - DirectorsTalk Interviews
Shareholders in QuidelOrtho (NASDAQ:QDEL) are in the red if they invested three years ago - Yahoo Finance
QuidelOrtho (NASDAQ:QDEL) Trading Down 3.8%Here's What Happened - MarketBeat
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now - Yahoo Finance
QuidelOrtho Adds Two Independent Directors to its Board - MPO-mag
QuidelOrtho Co. (NASDAQ:QDEL) Holdings Raised by SG Americas Securities LLC - MarketBeat
Merit Financial Group LLC Makes New $301,000 Investment in QuidelOrtho Co. (NASDAQ:QDEL) - Defense World
QuidelOrtho Co. (NASDAQ:QDEL) Receives $53.43 Consensus Target Price from Analysts - MarketBeat
QuidelOrtho Co. (NASDAQ:QDEL) Receives Consensus Recommendation of “Hold” from Analysts - Defense World
Clear Harbor Asset Management LLC Makes New Investment in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho Stock Down Despite Solid Preliminary Q4 Revenues - MSN
QuidelOrtho (NASDAQ:QDEL shareholders incur further losses as stock declines 6.4% this week, taking three-year losses to 59% - Simply Wall St
QuidelOrtho may be takeover, activist target with CEO exit, share slumpanalyst - MSN
Oak Thistle LLC Acquires New Stake in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho lets go off CEO Douglas Bryant - MSN
QuidelOrtho Breaks Below 200-Day Moving AverageNotable for QDEL - Nasdaq
QuidelOrtho (NASDAQ:QDEL) Stock Price Down 3.2%Here's Why - MarketBeat
Why QuidelOrtho Shares Are Struggling Despite Optimism - TipRanks
Moody National Bank Trust Division Grows Position in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho Corp (QDEL) Trading Down 4.21% on Jan 13 - GuruFocus.com
QuidelOrtho sees Q4 revenue $702M -$707M, consensus $698.04M - TipRanks
QuidelOrtho announces preliminary Q4 2024 revenue in range of $702 million to $707 million - MSN
QuidelOrtho reports Q4 revenue in line with guidance - Investing.com
QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024 - The Bakersfield Californian
Barclays PLC Sells 41,945 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
GAMMA Investing LLC Sells 640 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - Defense World
Quidel completes Ortho deal, emerges as QuidelOrtho - LabPulse
Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm - PR Newswire
JPMorgan Chase & Co. Has $56.25 Million Stock Holdings in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
JPMorgan Chase & Co. Sells 54,506 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - Defense World
Immunoassay Market Strategies, Trends. Forecasts Report 2025: The Drive Towards Newer, More Efficient Diagnostic Instruments - GlobeNewswire Inc.
QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace
QuidelOrtho Co. (NASDAQ:QDEL) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
QuidelOrtho Co. (NASDAQ:QDEL) Stock Position Increased by Principal Financial Group Inc. - MarketBeat
QuidelOrtho Co. (NASDAQ:QDEL) Holdings Raised by Principal Financial Group Inc. - Defense World
QuidelOrtho files to sell 8.26M shares of common stocks by selling shareholders - MSN
QuidelOrtho Co. (NASDAQ:QDEL) Shares Sold by Barclays PLC - MarketBeat
Geode Capital Management LLC Buys 16,059 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Does QuidelOrtho Corporation (QDEL) Have Healthy Long-Term Growth Prospects? - MSN
Insider Buying: QuidelOrtho President Bought US$250k Of Shares - Yahoo Finance
QuidelOrtho's SWOT analysis: stock upgrade amid cost cuts, product launch By Investing.com - Investing.com Australia
State Street Corp Boosts Holdings in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho's SWOT analysis: stock upgrade amid cost cuts, product launch - Investing.com
Quantinno Capital Management LP Trims Stock Position in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho Co. (NASDAQ:QDEL) Shares Sold by The Manufacturers Life Insurance Company - MarketBeat
Brian J. Blaser Buys 6,033 Shares of QuidelOrtho Co. (NASDAQ:QDEL) Stock - MarketBeat
QuidelOrtho Announces Appointment of Two Independent Directors to its Board - Milton Daily Standard
Citigroup Upgrades QuidelOrtho (QDEL) - MSN
Citi upgrades Quidel stock to Buy on FY25 growth prospects and margin improvement efforts - Investing.com
Quidelortho Corporation Azioni (QDEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):